Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.
Rhee TG, Shim SR, Forester BP, Nierenberg AA, McIntyre RS, Papakostas GI, Krystal JH, Sanacora G, Wilkinson ST.
JAMA Psychiatry. 2022 Dec 1;79(12):1162-1172. doi: 10.1001/jamapsychiatry.2022.3352.
Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults With Attention-Deficit/Hyperactivity Disorder: The TUNED Randomized Clinical Trial.
Leffa DT, Grevet EH, Bau CHD, Schneider M, Ferrazza CP, da Silva RF, Miranda MS, Picon F, Teche SP, Sanches P, Pereira D, Rubia K, Brunoni AR, Camprodon JA, Caumo W, Rohde LA.
JAMA Psychiatry. 2022 Sep 1;79(9):847-856. doi: 10.1001/jamapsychiatry.2022.2055.
Lurasidone for the treatment of bipolar depression: an evidence-based review.
Franklin R, Zorowitz S, Corse AK, Widge AS, Deckersbach T.
Neuropsychiatr Dis Treat. 2015 Aug 19;11:2143-52. doi: 10.2147/NDT.S50961. eCollection 2015.
Prevalence of cognitive impairment in major depression and bipolar disorder.
Douglas KM, Gallagher P, Robinson LJ, Carter JD, McIntosh VV, Frampton CM, Watson S, Young AH, Ferrier IN, Porter RJ.
Bipolar Disord. 2018 May;20(3):260-274. doi: 10.1111/bdi.12602. Epub 2018 Jan 18.
Predictors of switch from depression to mania in bipolar disorder.
Niitsu T, Fabbri C, Serretti A.
J Psychiatr Res. 2015 Jul-Aug;66-67:45-53. doi: 10.1016/j.jpsychires.2015.04.014. Epub 2015 Apr 22.
Bipolar disorder treatment according to illness trajectory: a systematic review of clinical trials.
Marchionatti LE, Antonelli-Salgado T, Erthal IN, Lopes SLS, Lucas LS, Rebouças DB, Passos IC.
Psychiatry Res. 2022 Jun;312:114572. doi: 10.1016/j.psychres.2022.114572. Epub 2022 Apr 25.
EEG alpha band characteristics in patients with a depressive episode within recurrent and bipolar depression.
Bokhan NA, Galkin SA, Vasilyeva SN.
Consort Psychiatr. 2023 Sep 29;4(3):5-12. doi: 10.17816/CP6140.
Suicidality in patients with bipolar depression: Findings from a lower middle-income country.
Xue S, Hodsoll J, Khoso AB, Husain MO, Chaudhry IB, Young AH, Zaheer J, Husain N, Mulsant BH, Husain MI.
J Affect Disord. 2021 Jun 15;289:1-6. doi: 10.1016/j.jad.2021.04.015. Epub 2021 Apr 17.
Efficacy and safety of scopolamine compared to placebo in individuals with bipolar disorder who are experiencing a depressive episode (SCOPE-BD): study protocol for a randomised double-blind placebo-controlled trial.
Miravalles C, Kane R, McMahon E, McDonald C, Cannon DM, Hallahan B.
Trials. 2022 Apr 23;23(1):339. doi: 10.1186/s13063-022-06270-4.
Development and validation of a Manic Thought Inventory.
Hanssen I, Ten Klooster P, Huijbers M, Lochmann van Bennekom M, Boere E, El Filali E, Geerling B, Goossens P, Kupka R, Speckens A, Regeer E.
Bipolar Disord. 2023 Nov;25(7):564-570. doi: 10.1111/bdi.13311. Epub 2023 Mar 8.
